Penn Medicine Abramson Cancer Center


 

ASH 2019 Update on AML: Frontline Regimen Driven by Genetic Subgroups Both For Prognosis and Therapy Choice

0 views
February 24, 2020
Comments 0
Login to view comments. Click here to Login